Independent market expert Ratnesh Kumar continues to remain positive on the IT sector, but says pharma as a whole is valuation-wise expensive. He is underweight on the auto-ancillary space and believes it is perhaps done with its best phase
first published: Oct 1, 2015 10:00 am
A collection of the most-viewed Moneycontrol videos.

Gold ETFs vs Silver ETFs | Which One Is Your Wealth Buddy?

Nifty Sees Triple-Digit Cut Despite Strong Q2 From SBI & M&M; All Sectors In Red | Closing Bell Live

Groww's Rs 6,632 Cr IPO Opens For Subscription | Management On Future Path | IPO Watch Live

Realty, PSU Banks Lead Nifty Back Near 25,800; Shriram Finance Scales Record High| Closing Bell Live
You are already a Moneycontrol Pro user.

